Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Cardiff Oncology, Inc. Common Stock (CRDF)

Biological Products, (no Disgnostic Substances)

https://www.cardiffoncology.com

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

11055 FLINTKOTE AVENUE
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/22/1997

Market Cap

106,220,925

Shares Outstanding

44,680,000

Weighted SO

44,677,169

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

RVPH --.--%

RVPH --.--%

EFTR --.--%

EFTR --.--%

PDSB --.--%

PDSB --.--%

NAVB --.--%

RVPHW --.--%

RVPHW --.--%

Beta

1.9360

Last Div

0.0000

Range

0.94-6.42

Chg

-0.0150

Avg Vol

594440

Mkt Cap

106220925

Exch

NASDAQ

Country

US

Phone

858 952 7570

DCF Diff

2.3081

DCF

0.0819

Div Yield

0.0000

P/S

159.7307

EV Multiple

-1.8674

P/FV

2.0321

Div Yield %

0.0000

P/E

-2.6057

PEG

-0.1280

Payout

-0.0006

Current Ratio

4.9709

Quick Ratio

4.9709

Cash Ratio

2.0365

DSO

247.5414

DIO

0.0000

Op Cycle

247.5414

DPO

4471.0312

CCC

-4223.4898

Gross Margin

0.3729

Op Margin

-67.1128

Pretax Margin

-61.4391

Net Margin

-61.4391

Eff Tax Rate

-0.0475

ROA

-0.6186

ROE

-0.6265

ROCE

-0.8338

NI/EBT

1.0000

EBT/EBIT

0.9155

EBIT/Rev

-67.1128

Debt Ratio

0.0279

D/E

0.0352

LT Debt/Cap

0.0213

Total Debt/Cap

0.0340

Int Coverage

-53.8359

CF/Debt

-17.3988

Equity Multi

1.2608

Rec Turnover

1.4745

Pay Turnover

0.0816

Inv Turnover

0.0000

FA Turnover

0.2624

Asset Turnover

0.0101

OCF/Share

-0.7154

FCF/Share

-0.7244

Cash/Share

1.3457

OCF/Sales

-48.2195

FCF/OCF

1.0126

CF Coverage

-17.3988

ST Coverage

-45.6781

CapEx Coverage

-79.5682

Div&CapEx Cov

-75.0960

P/BV

2.0321

P/B

2.0321

P/S

159.7307

P/E

-2.6057

P/FCF

-3.2715

P/OCF

-3.3200

P/CF

-3.3200

PEG

-0.1280

P/S

159.7307

EV Multiple

-1.8674

P/FV

2.0321

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation